Investigative Celiac Disease Drug KAN-101 Safe, Tolerable in Phase 1 Study
Early-stage data support KAN-101, a liver-targeting drug that's vying to become the first treatment approved to treat celiac disease.
Source: hcplive.com
Kan 101 News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Kan 101. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Kan 101 Today - Breaking & Trending Today